Buprenorphine transdermal skin patch and Sodium zirconium cyclosilicate
Determining the interaction of Buprenorphine transdermal skin patch and Sodium zirconium cyclosilicate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: sodium zirconium cyclosilicate
Brand name: Lokelma
Synonyms: Sodium Zirconium Cyclosilicate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Sofosbuvir
- Buprenorphine transdermal skin patch-Sofosbuvir and velpatasvir
- Buprenorphine transdermal skin patch-Sofosbuvir Tablets
- Buprenorphine transdermal skin patch-Sofosbuvir, velpatasvir, and voxilaprevir
- Buprenorphine transdermal skin patch-Sojourn
- Buprenorphine transdermal skin patch-Sojourn Inhalant
- Sodium zirconium cyclosilicate-Buprenorphine, Buprenorphine Hydrochloride
- Sodium zirconium cyclosilicate-Buprenorphine/naloxone Oromucosal, Sublingual
- Sodium zirconium cyclosilicate-Buproban
- Sodium zirconium cyclosilicate-Bupropion
- Sodium zirconium cyclosilicate-Bupropion and naltrexone
- Sodium zirconium cyclosilicate-Bupropion Extended-Release Tablets